Cadila Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Cadila Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011797
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cadila Pharmaceuticals Ltd (Cadila Pharmaceuticals) is a pharmaceutical company that develops, manufactures and distributes pharmaceutical products. The company’s products include active pharmaceutical ingredients (API) and pharmaceutical formulations. Its business includes contract research operation, contract manufacturing, herbal and agro divison. Cadila Pharmaceuticals products are used in the therapeutic areas of gastrointestinal, cardiovascular, anti-infectives and antibiotics, analgesics, haematinics, respiratory agents, immunologicals, oncology and antidiabetics, among others. The company’s products are in the form of capsules, tablets, orals, soft and hard gelatin capsules, and liquids. It has operations in Kenya, Nigeria, Ethiopia, the UK, Russia, the US, Sweden and Japan. Cadila Pharmaceuticals is headquartered in Ahmedabad, Gujarat, India.

Cadila Pharmaceuticals Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cadila Pharmaceuticals Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Aplagon Enters into Agreement with Cadila Pharma Sweden 11
Oncology Venture Enters into Co-Development Agreement with Cadila Pharma 12
Lipidor Enters into Agreement with Cadila Pharma 13
Axelar Enters into Co-Development Agreement with Cadila Pharma 14
Cadila Pharma Enters into Agreement with Respiratorius 15
NovaSAID Enters Into Co-Development Agreement With Cadila Pharma 16
Pergamum And Cadila Pharma Partner To Develop Novel Antibiotics For Infections 17
Licensing Agreements 18
Cadila Pharma and Altus Formulation Enter into Agreement 18
Cadila Pharma Enters into Licensing Agreement with Moberg Pharma 19
Cadila Pharma Enters Into Licensing Agreement With Helperby Therapeutics 20
Cadila Pharmaceuticals Ltd – Key Competitors 21
Cadila Pharmaceuticals Ltd – Key Employees 22
Cadila Pharmaceuticals Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 24
Recent Developments 25
Legal and Regulatory 25
Sep 02, 2016: Cadila Healthcare Receives Establishment Inspection Report For Ahmedabad 25
Aug 16, 2016: Cadila Healthcare provides Operational Update 26
Aug 16, 2016: Cadila Healthcare Receives Establishment Inspection Report For Changodar Facility 27
Other Significant Developments 28
Mar 22, 2016: Cadila Healthcare: Corporate Announcement 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cadila Pharmaceuticals Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Cadila Pharmaceuticals Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aplagon Enters into Agreement with Cadila Pharma Sweden 11
Oncology Venture Enters into Co-Development Agreement with Cadila Pharma 12
Lipidor Enters into Agreement with Cadila Pharma 13
Axelar Enters into Co-Development Agreement with Cadila Pharma 14
Cadila Pharma Enters into Agreement with Respiratorius 15
NovaSAID Enters Into Co-Development Agreement With Cadila Pharma 16
Pergamum And Cadila Pharma Partner To Develop Novel Antibiotics For Infections 17
Cadila Pharma and Altus Formulation Enter into Agreement 18
Cadila Pharma Enters into Licensing Agreement with Moberg Pharma 19
Cadila Pharma Enters Into Licensing Agreement With Helperby Therapeutics 20
Cadila Pharmaceuticals Ltd, Key Competitors 21
Cadila Pharmaceuticals Ltd, Key Employees 22
Cadila Pharmaceuticals Ltd, Other Locations 23
Cadila Pharmaceuticals Ltd, Subsidiaries 23
Cadila Pharmaceuticals Ltd, Joint Venture 24

★海外企業調査レポート[Cadila Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TTCL Public Company Limited (TTCL):電力:M&Aディール及び事業提携情報
    Summary TTCL Public Company Limited (TTCL), a subsidiary of Italian-Thai Development Public Company Limited, is a provider of engineering and construction services. The company offers integrated engineering, procurement and construction (EPC) services, feasibility study and project management servic …
  • Nobelpharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary NobelPharma Co Ltd (NobelPharma) is a pharmaceutical company that develops medicines for rare diseases and unmet medical needs. The company’s pipeline products include NPC-09, NPC-12, NPC-15, NPC-16, NPC-17 and NPC-18. It offers products in the therapeutic areas of oncology, metabolic diseas …
  • Arla Foods Ingredients Group P/S:企業の戦略・SWOT・財務情報
    Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report Summary Arla Foods Ingredients Group P/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Ceylon Hospitals PLC (CHL.N0000):企業財務及び戦略的SWOT分析
    Summary Ceylon Hospitals PLC (Durdans Hospitals) is a healthcare service provider that offers various medical and patient care services. The hospital offers services such as speech and language therapy, dental care, ENT care, emergency care, plastic and reconstructive surgery, laparoscopic surgery, …
  • LeMaitre Vascular Inc (LMAT):製品パイプライン分析
    Summary LeMaitre Vascular Inc (LeMaitre Vascular) is a medical device company. It undertakes the development, manufacture, marketing and sale of devices that are used in the treatment of peripheral vascular diseases. The company offers several product lines for vascular surgery and endovascular proc …
  • XL Group Ltd:戦略・SWOT・企業財務分析
    XL Group Ltd - Strategy, SWOT and Corporate Finance Report Summary XL Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • China Glass Holdings Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' China Glass Holdings Limited Me …
  • KM Corporation (083550):企業概要、財務及び戦略的SWOT分析
    Summary KM Corporation (KM) is an equipment manufacturer. The company manufactures and markets cast steel made of stainless steel. It conducts businesses through the division that include lost wax, shell casting, sand casting, machinery process, and various surface treatment methods. KM offers produ …
  • EnviroMission Limited (EVM):企業のM&A・提携動向(発電分野)
    Summary EnviroMission Limited (Enviro) is a renewable energy company that develops Solar Tower Technology (STT). It owns the license to STT across the world (excluding in China). The STT integrates the use of solar air collector and central updraft tower, to generate solar induced convective flow. I …
  • Haier Group:企業の戦略・SWOT・財務分析
    SummaryHaier Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Kohlberg Kravis Roberts & Co LP:企業のM&A・事業提携・投資動向
    Kohlberg Kravis Roberts & Co LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kohlberg Kravis Roberts & Co LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Agendia NV:企業のM&A・提携動向(医療機器分野)
    Summary Agendia NV (Agendia), a subsidiary of Agendia Inc. is a molecular diagnostic company that develops genomic diagnostic products. The company discovers, develops and commercializes products for the treatment of cancer. Its products include MammaPrint, BluePrint, TargetPrint, ColoPrint, TheraPr …
  • Southern California Gas Company:企業のM&A・提携動向(エネルギー分野)
    Summary Southern California Gas Company (SoCalGas), a subsidiary of Sempra Energy, is an energy utility. It stores, transmits and distributes natural gas. The company serves commercial, industrial, utility electricity generation and wholesale customers through natural gas franchises in its service t …
  • Altran Technologies SA:企業のM&A・提携・投資分析
    Altran Technologies SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Altran Technologies SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Gaz Metro Limited Partnership:企業のM&A・提携動向(エネルギー分野)
    Summary Gaz Metro Limited Partnership (Gaz Metro) is a midstream energy company. It is engaged in the distribution and production of natural gas. In addition, the company is also involved in the regulated activities relating to transportation and storage of natural gas as well as energy and other se …
  • Mipox Corporation (5381):企業概要、財務及び戦略的SWOT分析
    Summary Mipox Corporation (Mipox) is a chemical manufacturer. The company manufactures and sells polishing products. Its products include polishing films, polishing slurry, detergent and lubricant, polishing machines, cleaning products, variofilm and high functional film. Mipox offers customized dev …
  • Parsvnath Developers Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Parsvnath Developers Limited Me …
  • Advanced Digital Broadcast SA:企業の戦略的SWOT分析
    Advanced Digital Broadcast SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Cherkizovo Group OJSC (GCHE):企業の財務・戦略的SWOT分析
    Cherkizovo Group OJSC (GCHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Luxottica Group S.p.A.:企業の戦略・SWOT・財務情報
    Luxottica Group S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Luxottica Group S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆